Research and Development
AstraZeneca says its respiratory biologic meets primary endpoint in Phase III trial
May 17, 2016 Manufacturing and Production, Research and Development AstraZeneca, asthma drug, benralizumab, drug trial
Aduro’s pancreatic cancer immunotherapy fails Phase II trials; shares plunge
May 17, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets
Mylan to buy Renaissance’s dermatology business for up to $1 billion
May 16, 2016 Research and Development, Sales and Marketing Mylan, generics, merger and acquisition
Sanofi to replace entire Medivation board to drive sale, according to reports
May 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Medivation, Sanofi, replace board, takeover
Weekly Movers: Teva, Midatech, Allergan…
May 16, 2016 Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets
Novartis says trials show its COPD drug more effective versus GSK’s Seretide
May 16, 2016 Research and Development, Sales and Marketing GSK, Novartis, drug trial, research
Pfizer presents positive results in meningococcal disease late-stage trials
May 13, 2016 Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease
EU approves Idelvion for haemophilia B treatment
May 13, 2016 Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B
Sobi, Biogen’s haemophilia B therapy gets European approval
May 13, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi
Bayer terminates clinical trial for hypertension due to safety concerns
May 13, 2016 Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns
Takeda appoints new chief financial officer
May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe
Almost 9 in 10 CCGs not implementing NICE guidelines on antibiotic resistance
May 12, 2016 Research and Development, Sales and Marketing CCGs, NICE, antibiotic resistance, failure
BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer
May 12, 2016 Medical Communications, Research and Development, Sales and Marketing
Multiple myeloma treatment from BMS and AbbVie scores EU approval
May 12, 2016 Research and Development, Sales and Marketing AbbVie, BMS, EMA, EU, Empliciti, approval, bristl-myers squibb, elotuzumab, multiple myeloma
AstraZeneca says its trial drug for thyroid cancer granted US FDA orphan drug designation
May 12, 2016 Research and Development, Sales and Marketing AstraZeneca, Orphan Drug Designation, US FDA, drug trial, regulation
